HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$7.98
Day range
$7.44 - $7.87
Year range
$0.66 - $11.40
Market cap
226.93M USD
Avg Volume
11.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.19M | -2.30% |
Net income | -11.10M | -118.28% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -10.23M | -29.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.41M | -49.45% |
Total assets | 41.20M | -46.97% |
Total liabilities | 28.46M | -5.07% |
Total equity | 12.74M | — |
Shares outstanding | 29.35M | — |
Price to book | 18.14 | — |
Return on assets | -57.42% | — |
Return on capital | -64.45% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -11.10M | -118.28% |
Cash from operations | -7.42M | -7.80% |
Cash from investing | -27.00K | 90.22% |
Cash from financing | -121.00K | -436.11% |
Net change in cash | -7.57M | -6.25% |
Free cash flow | -3.96M | 21.77% |
About
Founded
2003
Headquarters
Website
Employees
42